Michael F. Bigham
2018
In 2018, Michael F. Bigham earned a total compensation of $1.9M as Executive Chairman of the Board at Paratek Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $330,000 |
|---|---|
| Salary | $500,000 |
| Stock Awards | $1,089,550 |
| Other | $22,890 |
| Total | $1,942,440 |
Bigham received $1.1M in stock awards, accounting for 56% of the total pay in 2018.
Bigham also received $330K in non-equity incentive plan, $500K in salary and $22.9K in other compensation.
Rankings
In 2018, Michael F. Bigham's compensation ranked 5,895th out of 14,244 executives tracked by ExecPay. In other words, Bigham earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,895 out of 14,244 | 59th |
Division Manufacturing | 2,238 out of 5,765 | 61st |
Major group Chemicals And Allied Products | 833 out of 2,128 | 61st |
Industry group Drugs | 696 out of 1,817 | 62nd |
Industry Pharmaceutical Preparations | 540 out of 1,391 | 61st |
Source: SEC filing on April 23, 2021.
Bigham's colleagues
We found two more compensation records of executives who worked with Michael F. Bigham at Paratek Pharmaceuticals in 2018.